Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesMalignant neoplasms of lip, oral cavity and pharynxICD-10-CM c07-malignant-neoplasm-of-parotid-gland
    Ask Trek AI about this page

    ICD-10-CM Code For Malignant Neoplasm Of Parotid Gland: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group C07 includes malignant neoplasms of the parotid gland, covering primary cancers arising in the major salivary gland of the cheek and adjacent parotid tissue. These ICD-10-CM diagnosis codes are used to document patients with confirmed malignant parotid tumors, capturing anatomic site, laterality when applicable, and associated clinical complexity. Accurate coding within the ICD-10-CM C07 group supports proper claim adjudication and complete clinical documentation for appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Malignant Neoplasm Of Parotid Gland: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM C07: Malignant Neoplasm Of Parotid Gland Overview

    The diagnoses in this group represent malignant tumors originating in the parotid salivary gland and surrounding parotid tissue. They target neoplastic disease of the head and neck region affecting salivary gland function and local structures. Accurate coding matters for clinical registry tracking, staging, and reimbursement because it links documented diagnosis to appropriate services and claims processing.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when clinical, histopathologic, or imaging evidence confirms a malignant neoplasm of the parotid gland. Assign the most specific code available to reflect tumor location and laterality to support clinical documentation and claims processing.

    ICD-10-CM Codes

    1 rows

    ICD-10-CM CodeDescription
    C07Malignant neoplasm of parotid gland

    DRG Codes

    6 rows

    DRG CodeDescription
    011Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with MCC
    012Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with CC
    013Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy without CC/MCC
    146Ear, Nose, Mouth and Throat Malignancy with MCC
    147Ear, Nose, Mouth and Throat Malignancy with CC
    148Ear, Nose, Mouth and Throat Malignancy without CC/MCC

    Typical Clinical Scenarios

    • A 62-year-old male presents to the head and neck oncology clinic with a several-month history of a firm, progressively enlarging, painless mass near the angle of the right jaw and recent facial nerve weakness. Imaging with MRI demonstrates a lobulated parotid gland mass suspicious for malignancy and ultrasound-guided core biopsy confirms invasive carcinoma of parotid origin, prompting staging and treatment planning; a diagnosis from this group is assigned to document the primary malignant parotid tumor. Typical codes: C07.
    • A 48-year-old female is evaluated in urgent care for rapidly enlarging swelling of the left parotid region with overlying skin erythema and low-grade fever; she reports prior diagnosis of a benign parotid lesion. Surgical pathology after emergent parotidectomy reveals malignant transformation of the previously known tumor, and the malignant parotid neoplasm code is used to report the active cancer as the principal diagnosis driving the acute intervention. Typical codes: C07.
    • A 71-year-old man with a history of treated parotid carcinoma presents to medical oncology for surveillance and is found to have new ipsilateral cervical lymphadenopathy and weight loss; biopsy of a lymph node confirms metastatic spread from the parotid primary. The malignant parotid neoplasm diagnosis is assigned as the underlying primary malignancy contributing to metastatic disease and ongoing cancer care. Typical codes: C07.

    Related Codes

    C00-MALIGNANT-NEOPLASM-OF-LIP

    ICD-10-CM Code For Malignant Neoplasm Of Lip: Group Overview

    C01-MALIGNANT-NEOPLASM-BASE-OF-TONGUE

    ICD-10-CM Code For Malignant Neoplasm Of Base Of Tongue: Group Overview

    C02-MALIGNANT-NEOPLASM-OF-TONGUE

    ICD-10-CM Code For Malignant Neoplasm Of Other And Unspecified Parts Of Tongue: Group Overview

    C03-MALIGNANT-NEOPLASM-OF-GUM

    ICD-10-CM Code For Malignant Neoplasm Of Gum: Group Overview

    C04-MALIGNANT-NEOPLASM-OF-FLOOR-OF-MOUTH

    ICD-10-CM Code For Malignant Neoplasm Of Floor Of Mouth: Group Overview

    C05-MALIGNANT-NEOPLASM-OF-PALATE

    ICD-10-CM Code For Malignant Neoplasm Of Palate: Group Overview

    C06-MALIGNANT-NEOPLASM-OF-MOUTH

    ICD-10-CM Code For Malignant Neoplasm Of Other And Unspecified Parts Of Mouth: Group Overview

    C08-MALIGNANT-SALIVARY-GLAND-NEOPLASMS

    ICD-10-CM Code For Malignant Neoplasm Of Other And Unspecified Major Salivary Glands: Group Overview

    C09-MALIGNANT-NEOPLASM-OF-TONSIL

    ICD-10-CM Code For Malignant Neoplasm Of Tonsil: Group Overview

    C10-MALIGNANT-NEOPLASM-OF-OROPHARYNX

    ICD-10-CM Code For Malignant Neoplasm Of Oropharynx: Group Overview

    Showing 1–10 of 14

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.